Indrayani Biotech Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Indrayani Biotech Ltd. on BSE

Load latest

Indrayani Biotech Ltd.

27 Nov 2022

14.77

11.98%

Result

INDRAYANI BIOTECH LTD. - 526445 - Disclosure On Related Party Transactions For The Half Year Ended …

BSE India

Pursuant to the Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the disclosure of Related Party Transactions (RPT) for the half year ended September 30, 2022.

pdf

Indrayani Biotech Ltd.

26 Nov 2022

14.77

11.98%

Corp. Note

INDRAYANI BIOTECH LTD. - 526445 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015.

pdf

Indrayani Biotech Ltd.

23 Nov 2022

14.77

11.98%

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, regarding Acquisition of a company by IBL Healthcare Limited, a wholly owned subsidiary of Indrayani Biotech Limited .

pdf

Indrayani Biotech Ltd.

16 Nov 2022

14.77

11.98%

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to the Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copy of newspaper publications pertaining to unaudited Financial Results for the quarter and half year ended September 30, 2022 published in "Trinity Mirror" in English Language and "Makkal Kural" in Tamil Language on November 16, 2022.

pdf

Indrayani Biotech Ltd.

14 Nov 2022

14.77

11.98%

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9th September, 2015, we are glad to inform that the company has acquired 40,800 equity shares constituting 51% of total no of equity shares of M/S Matrix Boilers Private Limited (MBPL), thus MBPL has become a subsidiary company of Indrayani Biotech Limited.

pdf

Indrayani Biotech Ltd.

14 Nov 2022

14.77

11.98%

Result

INDRAYANI BIOTECH LTD. - 526445 - Unaudited Financial Results For The Quarter And Half Year Ended …

BSE India

Unaudited Financial Results (Standalone and Consolidated) with the Limited Review Report of the Company for the quarter and half year ended September 30, 2022 (Q2), pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Indrayani Biotech Ltd.

14 Nov 2022

14.77

11.98%

Board Meeting

INDRAYANI BIOTECH LTD. - 526445 - Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial …

BSE India

Unaudited financial results (standalone and consolidated) of the Company for the quarter and half year ended September 30, 2022, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. A copy of the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2022, along with the Limited Review Report by the Auditors is attached. Investment of Rs.30,00,000 (Thirty Lakhs only) in the equity shares of Matrix Boilers Private Limited in order to acquire it as Subsidiary of our company. Loan of Rs.10,00,00,000 (Ten Crores only) to meet working capital requirement and other financial commitments of Matrix Boilers Private Limited.

pdf

Indrayani Biotech Ltd.

05 Nov 2022

14.77

11.98%

Board Meeting

INDRAYANI BIOTECH LTD. - 526445 - Board Meeting Intimation for Considering Unaudited Financial Results Pursuant To …

BSE India

INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve 1. The unaudited financial results (standalone and consolidated) of the Company for the quarter and half year ended September 30, 2022. 2. Any other business with the permission of the Chair.

pdf

Indrayani Biotech Ltd.

01 Nov 2022

14.77

11.98%

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Disclosure Regarding Intimation Of Delivery Of Work Order

BSE India

Kindly find the attachment for Intimation of delivery of work order

pdf

Indrayani Biotech Ltd.

14 Oct 2022, 12:29PM

14.77

11.98%

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Statement Of Investor Complaints For The Quarter Ended September 2022

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Kasiraman Sayee SundarDesignation :- Managing Director / Whole Time Director

Is Indrayani Biotech Ltd. worth buying?

26 Votes:

Buy 73.08%

Sell 11.54%

Hold 15.38%